Home FDA labels 5d1b51ad-dd9d-d4b1-e063-6394a90a8187 Pepto Bismol Liquicaps openFDA label record# This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)
Brand name Pepto Bismol Liquicaps
Generic name BISMUTH SUBSALICYLATE
Manufacturer The Procter & Gamble Manufacturing Company
Product type HUMAN OTC DRUG
SPL set ID 84ffa6d6-03e1-59e8-e053-2a91aa0afd6e
SPL ID 5d1b51ad-dd9d-d4b1-e063-6394a90a8187
Version 13
Effective date 2026-10-05
Source export date 2026-11-13
Source partition 10
Source file https://download.open.fda.gov/drug/label/drug-label-0010-of-0014.json.zip
Source object key raw/openfda/drug-label/2026-11-13/829e43b83940afb8dda22d5287c5b17e57d3fe45d1157678854b4f9b7ad07271/drug-label-0010-of-0014.json.zip
Source manifest SHA-256 8f2b6d063d44586cf97cedcdf1bdf9e261cc88632cc6855424b801bb206208d7
Import run 20261116T150851Z
Imported at 2026-11-16 17:15:17 Harmonized routes table Harmonized routes ORAL
Harmonized identifier links# Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
Harmonized identifiers page 1 of 1 · 16 matching rows.
Warnings cross-check# openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
Warnings sections page 1 of 1 · 1 matching rows.
warnings Warnings Reye's syndrome: Children and teenagers who have or are recovering from chicken pox or flu-like symptoms should not use this product. When using this product, if changes in behavior with nausea and vomiting occur, consult a doctor because these symptoms could be an early sign of Reye's syndrome, a rare but serious illness.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.